A detailed history of Connable Office Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Connable Office Inc holds 19,098 shares of ABT stock, worth $2.2 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
19,098
Previous 19,053 0.24%
Holding current value
$2.2 Million
Previous $1.98 Million 10.01%
% of portfolio
0.22%
Previous 0.22%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$100.07 - $118.13 $4,503 - $5,315
45 Added 0.24%
19,098 $2.18 Million
Q2 2024

Aug 06, 2024

SELL
$100.73 - $112.44 $3,223 - $3,598
-32 Reduced 0.17%
19,053 $1.98 Million
Q1 2024

Apr 30, 2024

SELL
$109.52 - $120.96 $469,731 - $518,797
-4,289 Reduced 18.35%
19,085 $2.17 Million
Q4 2023

Feb 12, 2024

SELL
$90.19 - $110.4 $13,528 - $16,560
-150 Reduced 0.64%
23,374 $2.57 Million
Q3 2023

Nov 08, 2023

BUY
$95.53 - $114.62 $2,579 - $3,094
27 Added 0.11%
23,524 $2.28 Million
Q1 2023

Apr 17, 2023

SELL
$96.86 - $114.01 $14,335 - $16,873
-148 Reduced 0.63%
23,497 $2.38 Million
Q3 2022

Oct 26, 2022

SELL
$96.76 - $112.03 $4,160 - $4,817
-43 Reduced 0.18%
23,645 $2.29 Million
Q2 2022

Aug 01, 2022

BUY
$102.07 - $123.37 $429,816 - $519,511
4,211 Added 21.62%
23,688 $2.57 Million
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $31,925 - $38,931
-280 Reduced 1.42%
19,477 $2.31 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $213,730 - $261,701
-1,850 Reduced 8.56%
19,757 $2.78 Million
Q3 2021

Nov 09, 2021

SELL
$116.66 - $129.06 $11,666 - $12,906
-100 Reduced 0.46%
21,607 $2.55 Million
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $77,649 - $91,405
-734 Reduced 3.27%
21,707 $2.52 Million
Q1 2021

May 07, 2021

BUY
$108.84 - $128.23 $89,466 - $105,405
822 Added 3.8%
22,441 $2.69 Million
Q3 2020

Nov 10, 2020

BUY
$91.64 - $111.29 $1.98 Million - $2.41 Million
21,619 New
21,619 $2.35 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Connable Office Inc Portfolio

Follow Connable Office Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connable Office Inc, based on Form 13F filings with the SEC.

News

Stay updated on Connable Office Inc with notifications on news.